Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × UNKNOWN × Albumin-Bound Paclitaxel × Clear all

Phase

Phase 2 4 Phase NA 1 Phase 4 1

Status

Sponsor Class

OTHER 4 UNKNOWN 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

toripalimab 1 pegylated granulocyte colony-stimulating factor 1 Idarubicin 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Growth Hormone 1 Cytarabine 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05291910 2022-03-23

Inetetamab Combined With Anti-PD-1 Monoclonal Antibody and Albumin-Bound Paclitaxel for HER2+ Metastatic Breast Cancer

ChineseAMS

Phase 4 Unknown

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡